Boehringer Ingelheim and IdeaSphere Announce Acquisition DealCattleNetwork.com, KS - Aug 28, 200625 /PRNewswire/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New York-based healthcare company, specializing in …
Read full story
Erbitux' success leads to €190m plant for Merck KGaAIn-PharmaTechnologist.com, France - 1 hour ago… The drug is currently manufactured in Europe by Boehringer Ingelheim, but this will change after the new plant comes on stream in 2010. … Merck Plans to Build Plant in Darmstadt to Produce Erbitux Drug BloombergMajor Investment in Germany: Merck KGaA Plans Biopharmaceutical … PharmaLive.com (press release)Merck KGaA To Invest EUR190 Million In New Biopharma Plant Easy Bourse (Communiqués de presse)all 9 news articles
Read full story
Ark down as losses growShareCast, UK - 3 hours ago… Last year’s revenue figure included the first £1.2m of initial milestone receipts due under the licensing agreement with Boehringer Ingelheim. … Ark Therapeutics H1 pretax loss widens as continues to develop … Life Style Extraall 3 news articles
Read full story
Jacobs inks Boehringer Ingelheim contractOutSourcing-Pharma.com, France - 2 hours ago29/08/2006 - Jacobs Engineering Group has inked a new contract with Boehringer Ingelheim to provide technical and construction services for its new bulk active …
Read full story
Boehringer Ingelheim and IdeaSphere announce acquisition dealAntara, Indonesia - Aug 27, 2006Ingelheim, New York and Lugano (ANTARA News/PRNewswire-AsiaNet) - Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New … Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal CattleNetwork.comBoehringer Ingelheim and IdeaSphere Announce Acquisition Deal Food Ingredients First (press release)all 4 news articles
Read full story
Merck Plans to Build Plant in Darmstadt to Produce Erbitux DrugBloomberg - 3 hours ago… The drug is currently being manufactured for Merck by Boehringer Ingelheim GmbH. Revenue from Erbitux rose 56 percent in the second quarter. … Merck KGaA To Invest EUR190 Million In New Biopharma Plant Easy Bourse (Communiqués de presse)all 6 news articles
Read full story
Boehringer Ingelheim and IdeaSphere announce acquisition dealChemie.de (press release), Germany - 2 hours ago08/29/2006 - Boehringer Ingelheim and IdeaSphere Inc. (ISI) announced the sale of Boehringer Ingelheim´s Natural Healthcare company …
Read full story
Bedford Laboratories(TM) to Begin Shipping Ciprofloxacin Injection …Yahoo! News (press release) - 2 hours ago… Headquartered in Bedford, Ohio, Bedford Laboratories is a division of Ben Venue Laboratories, Inc., a subsidiary of Boehringer Ingelheim Corporation located in …
Read full story
Boehringer Ingelheim and IdeaSphere Announce Acquisition DealNutrition horizon (press release), Netherlands - 28 minutes ago28/08/06 Boehringer Ingelheim has sold its Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere. Financial …
Read full story
Boehringer Ingelheim and IdeaSphere Announce Acquisition DealYahoo! News (press release) - Aug 25, 200625 /PRNewswire/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New York-based healthcare company, specializing in …
Read full story
Boehringer Ingelheim and IdeaSphere Announce Acquisition DealCNW Telbec (Communiqués de presse), Canada - Aug 25, 200625 /CNW/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New York-based healthcare company, specializing in vitamins … Boehringer Ingelheim and IdeaSphere announce acquisition deal Antaraall 4 news articles
Read full story
Boehringer Ingelheim and IdeaSphere Announce Acquisition DealPharmaLive.com (press release), PA - Aug 25, 2006INGELHEIM, Germany, NEW YORK and LUGANO, Switzerland, August 25, 2006 /PRNewswire/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and …
Read full story
Boehringer Ingelheim and IdeaSphere announce acquisition deal …WebWire (press release), GA - Aug 25, 2006Boehringer Ingelheim, the German based Pharmaceutical company, and IdeaSphere Inc. (ISI), the New York based Health Care company …
Read full story
Pramipexole Safe And Effective In Treating Restless Legs Syndrome …Medical News Today (press release), UK - Aug 25, 2006… Pramipexole, a compound from Boehringer Ingelheim research, is approved in the US for the treatment of the signs and symptoms of idiopathic Parkinson's disease …
Read full story
New Study of Depressive Symptoms in Parkinson's Disease Patients …International News Service, Australia - Aug 23, 2006… Pramipexole, a compound from Boehringer Ingelheim research, is approved for the treatment of the signs and symptoms of idiopathic Parkinson's disease. …
Read full story
AFX NEWS BRIEFING: Mergers and acquisitions highlights to 15:50 …Hemscott, UK - 9 hours ago… INGELHEIM, Germany (AFX) - Boehringer Ingelheim GmbH said it sold its natural healthcare business Pharmaton SA to New York-based IdeaSphere Inc. …
Read full story
Boehringer Ingelheim sells Pharmaton to IdeaSphere for undisclosed …Forbes - 1 hour agoINGELHEIM, Germany (AFX) - Boehringer Ingelheim GmbH said it sold its natural healthcare business Pharmaton SA to New York-based IdeaSphere Inc. … Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal Yahoo! News (press release)Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal Canada NewsWire (press release)all 6 related
Read full story
Jacobs receives contract from Boehringer Ingelheim ChemicalsConstruction and Maintenance News, Belarus - 1 hour agoJacobs Engineering Group Inc. received a contract from Boehringer Ingelheim Chemicals, Inc. (BICI) to provide preliminary and detail …
Read full story
Jacobs Receives Contract From Boehringer Ingelheim Chemicals, Inc.PR Newswire (press release), NY - Aug 22, 200622 /PRNewswire-FirstCall/ — Jacobs Engineering Group Inc. (NYSE: JEC) announced today that they received a contract from Boehringer Ingelheim Chemicals, Inc. …
Read full story
Express PharmaGlenmark gets USFDA nod to market generic MeloxicamExpress Pharma, India - 5 hours agoGlenmark received USFDA approval to market Meloxicam oral tablets 7.5 milligram and 15 milligram, a generic version of Boehringer Ingelheim's brand, Mobic. …
Read full story